oxymatrine has been researched along with sodium arsenite in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (sodium arsenite) | Trials (sodium arsenite) | Recent Studies (post-2010) (sodium arsenite) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 1,362 | 3 | 529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Han, X; Li, C; Liu, R; Ma, Z; Xie, R; Yang, L; Yang, Q; Zhang, J | 1 |
1 other study(ies) available for oxymatrine and sodium arsenite
| Article | Year |
|---|---|
[Rat serum containing oxymatrine inhibits the proliferation of LX2 human hepatic stellate cells induced by sodium arsenite via blocking PI3K/AKT pathway].
Topics: Alkaloids; Animals; Arsenic; Arsenites; bcl-2-Associated X Protein; Cell Proliferation; Cyclin D1; Hepatic Stellate Cells; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Rats; Rats, Sprague-Dawley; Sodium Compounds | 2022 |